501 studies found for:    "Growth Hormone"
Show Display Options
Rank Status Study
1 Recruiting Growth Hormone Use in Albright Hereditary Osteodystrophy
Conditions: Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone
2 Terminated Growth Hormone in Poor Responders to IVF Trial
Condition: Infertility
Interventions: Drug: Saizen (Human Growth Hormone);   Drug: No Saizen Control (Standard IVF Protocol)
3 Completed
Has Results
Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency
Conditions: Childhood-onset Growth Hormone Deficiency;   Pituitary Dwarfism
Intervention: Biological: recombinant human growth hormone
4 Completed
Has Results
Effects of Short-term Growth Hormone in HIV-infected Patients
Condition: HIV Lipodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone Releasing Hormone
5 Active, not recruiting Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
Condition: Idiopathic Short Stature
Interventions: Drug: Aromatase Inhibitor;   Drug: Growth Hormone;   Drug: Aromatase Inhibitor and Growth Hormone
6 Unknown  Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Condition: Hypothyroidism
Interventions: Drug: Growth hormone;   Drug: Growth hormone treatment and puberty
7 Suspended American Norditropin Studies - Registry of Growth Hormone (GH) Patients
Condition: Growth Hormone Deficiency
Intervention: Drug: Norditropin Growth Hormone
8 Recruiting An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Growth Hormone Deficiency (GHD) of Adult Onset
Condition: Growth Hormone Deficiency
Intervention: Drug: Saizen® solution for injection (referred as Saizen®)
9 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)
10 Not yet recruiting Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
Condition: Female Infertility Due to Diminished Ovarian Reserve
Interventions: Drug: Human Growth Hormone;   Drug: Follicle Stimulating Hormone
11 Completed Effects of Growth Hormone (GH) Treatment on Eating Regulation
Condition: Short Stature
Interventions: Behavioral: growth hormone- Genotropin or NorditropinSimplex and nutritional intervention;   Behavioral: growth hormone-Genotropin or NorditropinSimplex or "Biotropin"
12 Completed
Has Results
Saizen in Intra-uterine Growth Retardation
Condition: Children Born With Serious Intra-uterine Growth Retardation
Interventions: Drug: Saizen® A;   Drug: Saizen® B;   Other: Observation only
13 Completed
Has Results
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
Condition: Obesity
Interventions: Drug: Nutropin AQ growth hormone;   Drug: Placebo Growth Hormone
14 Completed Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
Condition: Growth Hormone Deficiency
Interventions: Drug: pegylated Somatropin;   Drug: Jintropin AQ
15 Completed Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Pegylated-Somatropin in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Pegylated-Somatropin;   Drug: YPEG-Somatropin
16 Completed Growth Hormone to Increase Immune Function in People With HIV
Condition: HIV Infections
Intervention: Drug: Somatropin (recombinant human growth hormone)
17 Completed
Has Results
Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age
Condition: Small for Gestational Age (SGA)
Intervention: Drug: Saizen®
18 Unknown  Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Growth Hormone;   Dietary Supplement: Nutraceutical Combination;   Other: Exclusion Diet;   Other: Placebo Growth Hormone
19 Active, not recruiting Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children
Condition: Hypochondroplasia
Intervention: Drug: Recombinant human growth hormone (Somatropin)
20 Not yet recruiting Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma Syndrome
Intervention: Biological: Human recombinant growth hormone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years